We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Gene Protects Against Tumors

By Biotechdaily staff writers
Posted on 14 Dec 2005
A gene that is important in immune function appears to also be critical in suppressing chronic lung inflammation and tumor development in mice, according to a new study, suggesting it may help to fight cancer.

The immune system has two components, the innate and the acquired. A gene known as toll-like receptor 4 (TLR4) is part of the innate immune system, which forms the front line of defense against infection. To determine the role of TLR4 in inflammation, the researchers gave mice prone to lung cancer a preservative known to cause lung inflammation. Primary tumor formation also was measured in mice known to have cancer. Mice with both functional and altered TLR4 were used in all protocols. The results showed that mice that had TLR4 removed or altered had 60% more tumors than mice that had intact receptors, showing a protective role for the gene. The findings were reported in the December 7, 2005, issue of the "Journal of the [U.S.] National Cancer Institute.

"We can't attribute the number of tumors per mouse to TLR4 alone, but it accounts for a significant portion of it,” said Steven Kleeberger, Ph.D., chief, laboratory of respiratory biology at the U.S. National Institute of Environmental Health Sciences (NIEHS, Bethesda, MD, USA), which conducted the research. "TLR4 acts like the brake of a car,” he explained. "If you take the brake or receptor away, you see more increases in tumor development, more inflammation, and more mortality.”

Prior research has indicated an association between chronic lung inflammation and lung cancer but the mechanisms were not well understood. Chronic bronchitis and asthma, for example, are known to increase the risk of lung cancer. Inflammation has been implicated as a contributing factor to several human cancers.

"What we found is the innate immune system, particularly TLR4, plays a critical role in protecting against the development of tumors and chronic inflammation,” said lead author Alison Bauer, Ph.D. "It suggests that targeting the innate immune system may be a useful tool in fighting a variety of human diseases, including cancer.”





Related Links:
U.S. NIEHS

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
ESR Analyzer
TEST1 2.0

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
14 Dec 2005  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
14 Dec 2005  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
14 Dec 2005  |   BioResearch